Mobilization efficiency of granulocyte colony-stimulating factor and stem cell factor to bone marrow mononuclear cells and mechanisms

Abstract

The mobilization efficiency of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) to bone marrow mononuclear cells (MNCs) in mice was observed, and the changes of CXCL12/CXCR4 signal were detected in order to find out the mobilization mechanism of stem cells. Kunming mice were randomly divided into two groups. The mice in treatment group were subjected to subcutaneous injection of G-CSF at a dose of 100 μg/kg and SCF at a dose of 25 μg/kg every day for 5 days, and those in control group were given isodose physiological saline. The MNCs were separated, counted and cultured, and the colony-forming unit-fibroblast (CFU-F) was evaluated. CD34⁺CXCR4⁺ MNCs were sorted by flow cytometry. The expression of CXCL12 protein in bone marrow extracellular fluid was detected by ELISA, and that of CXCL12 mRNA in bone marrow was measured by RT-PCR. The results showed that the counts of MNCs in peripheral blood and bone marrow were increased after administration of G-CSF/SCF (P<0.01). The factors had a dramatic effect on the expansion capability of CFU-F (P<0.05). Flow cytometric of bone marrow MNCs surface markers revealed that CD34⁺CXCR4⁺ cells accounted for 44.6%±8.7% of the total CD34⁺ MNCs. Moreover, G-CSF/SCF treatment induced a decrease in bone marrow CXCL12 mRNA that closely mirrored the fall in CXCL12 protein. In this study, it is evidenced that G-CSF/SCF can effectively induce MNCs mobilization by disrupting the balance of CXCL12/CXCR4 signaling pathway in the bone marrow and down-regulating the interaction of CXCL12/CXCR4.

Keywords

granulocyte colony-stimulating factor / stem cell factor / mononuclear cell / mobilization

References

[1] KhanM., ManzoorS., MohsinS., et al.. IGF-1 and G-CSF complement each other in BMSC migration towards infarcted myocardium in a novel in vitro model. Cell Biol Int, 2009, 33(6): 650-657

[2] PiaoC.S., Gonzalez-ToledoM.E., XueY.Q., et al.. The role of stem cell factor and granulocyte-colony stimulating factor in brain repair during chronic stroke. J Cereb Blood Flow Metab, 2009, 29(4): 759-770

[3] WuX., YangS., DuanD., et al.. A combination of granulocyte colony-stimulating factor and stem cell factor ameliorates steroid-associated osteonecrosis in rabbits. J Rheumatol, 2008, 35(11): 2241-2248

[4] KlockeR., KuhlmannM.T., ScobioalaS., et al.. Granulocyte colony-stimulating factor (G-CSF) for cardio- and cerebrovascular regenerative applications. Curr Med Chem, 2008, 15(10): 968-977

[5] HussR.. Isolation of primary and immortalized CD34⁻ hematopoietic and mesenchymal stem cells from various sources. Stem Cells, 2000, 18(1): 1-9

[6] HerzogE.L., ChaiL., KrauseD.S.. Plasticity of marrow-derived stem cells. Blood, 2003, 102(10): 3483-3493

[7] ChenC.P., LeeY.J., ChiuS.T., et al.. The application of stem cells in the treatment of ischemic diseases. Histol Histopathol, 2006, 21(11): 1209-1216

[8] LapidotT., PetitI.. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol, 2002, 30(9): 973-981

[9] LarsenS.R., ChngK., BattahF., et al.. Improved granulocyte colony-stimulating factor mobilization of hemopoietic progenitors using cytokine combinations in primates. Stem Cells, 2008, 26(11): 2974-2980

[10] HoferM., VacekA., PospísilM., et al.. Activation of adenosine A(3) receptors potentiates stimulatory effects of IL-3, SCF, and GM-CSF on mouse granulocyte-macrophage hematopoietic progenitor cells. Physiol Res, 2009, 58(2): 247-252

[11] OrlicD., KajsturaJ., ChimentiS., et al.. Bone marrow cells regenerate infarcted myocardium. Nature, 2001, 410(6829): 701-705

[12] PetitI., Szyper-KravitzM., NaglerA., et al.. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol, 2002, 3(7): 687-694

[13] KortesidisA., ZannettinoA., IsenmannS., et al.. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood, 2005, 105(10): 3793-3801

[14] DarA., GoichbergP., LapidotT., et al.. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol, 2005, 6(10): 1038-1046

[15] HeissigB., HattoriK., DiasS., et al.. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit ligand. Cell, 2002, 109(5): 625-637

[16] CarstanjenD., UlbrichtN., IaconeA., et al.. Matrix metalloproteinase-9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G-CSF. Transfusion, 2002, 42(5): 588-596

[17] MoserB., WolfM., WalzA., et al.. Chemokines: multiple levels of leukocyte migration control. Trends Immunol, 2004, 25(2): 75-84

[18] PeledA., KolletO., PonomaryovT., et al.. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood, 2000, 95(11): 3289-3296

[19] WrightL.M., MaloneyW., YuX., et al.. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone, 2005, 36(5): 840-853